396 related articles for article (PubMed ID: 17433041)
1. Possible role of gadolinium in nephrogenic systemic fibrosis: report of two cases and review of the literature.
Lim YL; Lee HY; Low SC; Chan LP; Goh NS; Pang SM
Clin Exp Dermatol; 2007 Jul; 32(4):353-8. PubMed ID: 17433041
[TBL] [Abstract][Full Text] [Related]
2. Gadolinium-associated nephrogenic systemic fibrosis: the need for nephrologists' awareness.
Canavese C; Mereu MC; Aime S; Lazzarich E; Fenoglio R; Quaglia M; Stratta P
J Nephrol; 2008; 21(3):324-36. PubMed ID: 18587720
[TBL] [Abstract][Full Text] [Related]
3. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure.
Grobner T; Prischl FC
Semin Dial; 2008; 21(2):135-9. PubMed ID: 18226001
[TBL] [Abstract][Full Text] [Related]
4. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis in 2 patients with end-stage renal disease on hemodialysis.
Kim RH; Ma L; Hayat SQ; Ahmed MM
J Clin Rheumatol; 2006 Jun; 12(3):134-6. PubMed ID: 16755242
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for developing gadolinium-induced nephrogenic systemic fibrosis.
Peak AS; Sheller A
Ann Pharmacother; 2007 Sep; 41(9):1481-5. PubMed ID: 17684032
[TBL] [Abstract][Full Text] [Related]
6. Extracorporeal photopheresis improves nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: three case reports and review of literature.
Mathur K; Morris S; Deighan C; Green R; Douglas KW
J Clin Apher; 2008; 23(4):144-50. PubMed ID: 18633995
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium and nephrogenic systemic fibrosis: association or causation.
Kurtkoti J; Snow T; Hiremagalur B
Nephrology (Carlton); 2008 Jun; 13(3):235-41. PubMed ID: 18221255
[TBL] [Abstract][Full Text] [Related]
8. [Nephrogenic systemic fibrosis].
Breitschaft A; Stahlmann R
Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
[TBL] [Abstract][Full Text] [Related]
9. Nephrogenic systemic fibrosis: a gadolinium-associated fibrosing disorder in patients with renal dysfunction.
Kay J
Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii66-9. PubMed ID: 19022818
[TBL] [Abstract][Full Text] [Related]
10. Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.
Chen W; Huang SL; Huang CS; Tsai MC; Lai HM; Lui CC; Eng HL; Chang HW; Lee CH; Chuang FR
Eur J Dermatol; 2009; 19(1):44-9. PubMed ID: 19059824
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous changes of nephrogenic systemic fibrosis: predictor of early mortality and association with gadolinium exposure.
Todd DJ; Kagan A; Chibnik LB; Kay J
Arthritis Rheum; 2007 Oct; 56(10):3433-41. PubMed ID: 17907148
[TBL] [Abstract][Full Text] [Related]
12. Nephrogenic fibrosing dermopathy associated with exposure to gadolinium-containing contrast agents--St. Louis, Missouri, 2002-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 Feb; 56(7):137-41. PubMed ID: 17318112
[TBL] [Abstract][Full Text] [Related]
13. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.
Deo A; Fogel M; Cowper SE
Clin J Am Soc Nephrol; 2007 Mar; 2(2):264-7. PubMed ID: 17699423
[TBL] [Abstract][Full Text] [Related]
14. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
Broome DR
Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
[TBL] [Abstract][Full Text] [Related]
15. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature.
Introcaso CE; Hivnor C; Cowper S; Werth VP
Int J Dermatol; 2007 May; 46(5):447-52. PubMed ID: 17472669
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury.
Kalb RE; Helm TN; Sperry H; Thakral C; Abraham JL; Kanal E
Br J Dermatol; 2008 Mar; 158(3):607-10. PubMed ID: 18076707
[TBL] [Abstract][Full Text] [Related]
17. Transmetallation and gadolinium: do low iron stores prevent the development of nephrogenic systemic fibrosis in high-risk end-stage renal disease patients?
Panesar M; Boateng F; Patel SS; Masood SF; Mahajan P; Patel N; Murray B
Hemodial Int; 2010 Jul; 14(3):289-94. PubMed ID: 20662951
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminases: the missing link in nephrogenic systemic fibrosis.
Parsons AC; Yosipovitch G; Sheehan DJ; Sangüeza OP; Greenberg CS; Sane DC
Am J Dermatopathol; 2007 Oct; 29(5):433-6. PubMed ID: 17890909
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
[TBL] [Abstract][Full Text] [Related]
20. Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis with diaphragmatic involvement in a patient with respiratory failure.
Kucher C; Steere J; Elenitsas R; Siegel DL; Xu X
J Am Acad Dermatol; 2006 Feb; 54(2 Suppl):S31-4. PubMed ID: 16427988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
